IVX Health

What IVX Health does

IVX Health is a US-based, privately held outpatient healthcare services company that operates a national network of stand-alone infusion and injection centers delivering specialty biologic therapies to patients with complex chronic conditions including Crohn's disease, ulcerative colitis, multiple sclerosis, rheumatoid arthritis, psoriasis, lupus, and severe asthma. Founded in 2012 and headquartered in Brentwood, Tennessee, the company operates across 16 states with 501-1,000 employees, administering more than 60 biologic infusion and injection therapies. Each center is a physical, appointment-only facility featuring six private patient suites per location, a 1:3 nurse-to-patient ratio, evening and Saturday scheduling, and amenities such as leather recliners, streaming TVs, Wi-Fi, and free parking, with pediatric services supported by PALS-certified nurses and pediatric-specific protocols under a Pediatric Medical Director.

The company's underlying platform is its real estate and clinical operations footprint, supplemented by a patient-facing payment portal, online appointment request system, virtual tour capability, and provider-facing referral infrastructure including downloadable therapy-specific order forms. Technology differentiators focus on care delivery rather than software; the only disclosed data-related capability is the October 2020 acquisition of Precisionhc, for which the specific function is not detailed.

IVX Health generates revenue by administering biologic infusion and injection therapies on a per-encounter basis, billing commercial insurance, Medicare, and Medicaid as outpatient medical benefits with prior authorization. Patient copays, coinsurance, and deductibles are collected at time of service. The go-to-market motion is sales-led and physician-referral-driven, supported by direct field sales targeting rheumatologists, gastroenterologists, neurologists, and pulmonologists, with supplemental patient acquisition via content marketing, social media, and online search. As of the most recent disclosed capital event, the company had raised approximately $136 million cumulatively, with a $100 million Series F growth investment from Great Hill Partners in September 2021 funding continued geographic expansion.

Name

IVX Health

Legal name

IVXpress, Inc.

Website

https://ivxhealth.com

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

501–1,000 employees

Short description

IVX Health operates a national network of stand-alone outpatient infusion and injection centers across 16 US states, administering over 60 biologic therapies to adult and pediatric patients with complex chronic conditions on a physician-referral, insurance-billed basis.

Ownership category

akta.pro rank

Product category

Outpatient Infusion Services

NAICS

Outpatient Care Centers (6214), Other Outpatient Care Centers (62149), Offices of Physicians (except Mental Health Specialists) (621111)

SIC

Services-Specialty Outpatient Facilities, Nec (8093), Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Infusion Therapy Centers (Outpatient) (HLAFABAF)

akta.pro secondary industry

Infusion & Home Infusion Pharmacy Services (HLAFALAG)

Keywords

• Outpatient infusion services
• Biologic injection therapy
• Specialty infusion centers
• Chronic disease treatment
• Infusion therapy provider

Headquarters

HQ city

Brentwood

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Supply Chain, Marketing or Sales, Technology or R&D

Revenue model

1. Specialty Biologic Infusion and Injection Therapy: IVX Health generates revenue by administering specialty biologic infusion and injection therapies for patients with complex chronic conditions. Services are billed to patients' health insurance plans (commercial insurance, Medicare, Medicaid) as outpatient medical treatments. The company accepts most major commercial insurances and maintains in-network status with numerous payors across 15+ states. Patient copays, coinsurance, and deductibles are collected at time of service.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels6 records

Core offering

IVX Health operates a national network of standalone outpatient infusion and injection centers delivering biologic infusion and injection therapies for adult and pediatric patients with complex chronic conditions including Crohn's disease, ulcerative colitis, multiple sclerosis, rheumatoid arthritis, lupus, psoriasis and severe asthma. Each center provides guaranteed private patient suites, flexible scheduling including evenings and Saturdays, and a 1:3 nurse-to-patient ratio. Services are administered by ARNPs, RNs and physician medical directors, billed to commercial insurance, Medicare and Medicaid, and accessed via physician referral.

Product overview

IVX Health is a national network of outpatient infusion and injection centers providing biologic therapies for patients with complex chronic conditions. The core offering consists of IVX Health Infusion & Injection Centers (main product), supplemented by specialized Pediatric Infusion Care services. The company administers over 60 biologic infusion and injection therapies including treatments for Crohn's disease, ulcerative colitis, multiple sclerosis, rheumatoid arthritis, psoriasis, lupus, severe asthma, and numerous other conditions. Additional service features include private patient suites, flexible scheduling (weekday, evening, Saturday), a 1:3 nurse-to-patient ratio, online appointment requests, and a patient payment portal. The company operates across 16 states including Arkansas, California, Connecticut, Delaware, Florida, Illinois, Indiana, Kansas, Missouri, New Jersey, New York, North Carolina, Ohio, Pennsylvania, Tennessee, and Texas.

Differentiator

Problem solved

Functional benefit

Products and services

• IVX Health Infusion & Injection Centers

Quantifiable outcome

• 99% patient satisfaction (Q4-2019 Patient Satisfaction Survey)
• +3 more outcomes

Named customers5 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Scale indicators4 records

Recent moves8 records

Expansion highlights6 records

Direct peers

• Pentec Health: Specialty infusion and nutrition provider focused on complex chronic and rare disease patients. Comparable therapy portfolio and clinical complexity, though smaller footprint.
• Soleo Health: Specialty infusion services provider focused on complex chronic conditions across immunology, neurology, and rare diseases. Comparable in therapy portfolio and payor contracting approach, with both home and site-of-care delivery.
• Option Care Health: Largest independent U.S. provider of home and alternate-site infusion services, including specialty biologics for autoimmune and chronic conditions. Most direct comparable in terms of therapy mix and patient population, though Option Care is home-infusion-led rather than center-led.
• Vivo Infusion: Operates outpatient infusion centers focused on specialty biologics with a similar physician-referral and insurance-billing model. Closest center-format direct competitor, though smaller in geographic reach than IVX.
• InfuSystem Holdings: Provider of infusion pumps and related services to hospitals, oncology clinics, and alternate sites. Comparable in alternate-site infusion delivery, though more pump-centric and less therapy-focused.
• Amerita: Specialty home infusion provider serving patients with chronic conditions across multiple states. Overlaps with IVX on therapy list and patient population, but delivers primarily in the home setting.

Broad incumbents

• Accredo (Cigna / Evernorth): Specialty pharmacy and infusion arm of Evernorth (Cigna) that delivers high-cost biologics to chronic disease patients. Embedded within Express Scripts payor network, competing on formulary access and site of care.
• Coram (CVS Health): CVS-owned national home infusion provider that competes for the same chronic biologic infusion patients, primarily in home settings. Backed by CVS's payor and specialty pharmacy assets.
• Optum Infusion (UnitedHealth Group): UnitedHealth-owned infusion services platform with national reach and embedded payor relationships through UnitedHealthcare. Competes for the same commercial and Medicare lives that IVX serves.
• Hospital Outpatient Infusion Departments (e.g., HCA, Ascension, Tenet): Large hospital systems operate infusion centers within outpatient departments that compete for the same patients. Historically dominant site of care for specialty biologics and a key competitor for referrals.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/IVX-Health-107722457239891
• LinkedInlinkedin.com/company/ivx-health
• Instagraminstagram.com/ivxhealth

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds4 records

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about IVX Health